MAF1 activators are a class of chemical compounds that specifically enhance the functional activity of the MAF1 protein. MAF1, a highly conserved negative regulator of RNA polymerase III (Pol III), has a crucial role in the repression of Pol III transcription in response to various cellular stresses. The activation of MAF1 is a complex process that involves multiple signaling pathways, including those related to nutrient availability, cellular energy status, and stress responses. Chemical activators of MAF1 often function by influencing these signaling cascades to elicit a cellular response that culminates in the enhanced repression of Pol III activity. For instance, certain phosphatase inhibitors can lead to dephosphorylation of MAF1, which is a prerequisite for its nuclear localization and subsequent repression of Pol III-driven transcription. Other compounds may activate AMP-activated protein kinase (AMPK), which in turn phosphorylates MAF1, promoting its repressor function. Additionally, molecules that modulate the mTOR pathway can impact MAF1 activity because mTOR signaling inversely affects MAF1's ability to repress Pol III transcription. These activators do not act by increasing the expression levels of MAF1, but rather by modulating its post-translational modifications and its interaction with Pol III and associated transcriptional machinery.
The biochemistry underlying MAF1 activators is centered around the fine-tuning of MAF1's repressive capabilities, which is essential for maintaining cellular homeostasis and response to metabolic stress. Certain activators may work by altering the phosphorylation state of MAF1 through the inhibition of kinases such as mTOR, which when active, phosphorylates MAF1, leading to its cytoplasmic sequestration and inactivation. By inhibiting such kinases, MAF1 remains in a dephosphorylated state, actively repressing Pol III transcription. Other activators may mimic cellular stress signals, which are known to enhance MAF1's interaction with the Pol III complex. This interaction is critical in downregulating the synthesis of small RNAs and tRNAs, which are required for rapid cell growth and proliferation. Through the modulation of these and other related pathways, MAF1 activators exert a pivotal influence on gene expression control, facilitating the cell's ability to conserve resources and maintain energy efficiency in response to cellular stress conditions. The specificity and direct action of these compounds on MAF1's activity highlight their significance in the biochemical modulation of gene expression without affecting the transcription or translation of MAF1 itself.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels which, through PKA activation, could lead to phosphorylation events influencing MAF1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, increasing cAMP levels, which may enhance MAF1 activity via PKA signaling pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cAMP analog that activates PKA, potentially enhancing MAF1 activity through phosphorylation events. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can indirectly influence MAF1 activity through modulation of cellular energy states. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin activates AMPK, possibly affecting MAF1 activity by altering the energy balance within the cell. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which could deacetylate and thus potentially enhance the activity of MAF1. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SRT1720 is a SIRT1 activator, which may lead to deacetylation and enhanced activity of MAF1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor which could alter MAPK signaling, potentially affecting MAF1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which might indirectly enhance MAF1 activity by influencing stress response pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates multiple signaling pathways, which may include indirect activation of MAF1 through anti-inflammatory effects. | ||||||